ZA200106499B - Methods for treating ovarian cancer, poly(phosphoester) compositions, and biodegradable articles for same. - Google Patents
Methods for treating ovarian cancer, poly(phosphoester) compositions, and biodegradable articles for same.Info
- Publication number
- ZA200106499B ZA200106499B ZA200106499A ZA200106499A ZA200106499B ZA 200106499 B ZA200106499 B ZA 200106499B ZA 200106499 A ZA200106499 A ZA 200106499A ZA 200106499 A ZA200106499 A ZA 200106499A ZA 200106499 B ZA200106499 B ZA 200106499B
- Authority
- ZA
- South Africa
- Prior art keywords
- ovarian cancer
- compositions
- methods
- phosphoester
- poly
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/908—Mechanical repair performed/surgical
- Y10S977/911—Cancer cell destruction
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/908—Mechanical repair performed/surgical
- Y10S977/912—Cancer cell repair
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Biological Depolymerization Polymers (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/227,852 US6350464B1 (en) | 1999-01-11 | 1999-01-11 | Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200106499B true ZA200106499B (en) | 2002-11-07 |
Family
ID=22854735
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200106499A ZA200106499B (en) | 1999-01-11 | 2001-08-07 | Methods for treating ovarian cancer, poly(phosphoester) compositions, and biodegradable articles for same. |
Country Status (20)
Country | Link |
---|---|
US (4) | US6350464B1 (fr) |
EP (1) | EP1140028B1 (fr) |
JP (1) | JP2002534456A (fr) |
KR (1) | KR20010101472A (fr) |
CN (1) | CN1337878A (fr) |
AT (1) | ATE310506T1 (fr) |
AU (1) | AU779182B2 (fr) |
BR (1) | BR9916881A (fr) |
CA (1) | CA2359109C (fr) |
CZ (1) | CZ20012416A3 (fr) |
DE (1) | DE69928567T2 (fr) |
HU (1) | HUP0202670A3 (fr) |
IL (2) | IL145087A0 (fr) |
IN (1) | IN2001CH01053A (fr) |
MX (1) | MX236541B (fr) |
NO (1) | NO20013402L (fr) |
RU (1) | RU2001122708A (fr) |
TR (1) | TR200102012T2 (fr) |
WO (1) | WO2000041678A1 (fr) |
ZA (1) | ZA200106499B (fr) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2335460A1 (fr) | 1998-06-18 | 1999-12-23 | Johns Hopkins University School Of Medicine | Methodes et reactifs d'administration intramusculaire d'acides nucleiques |
US6537585B1 (en) | 1999-03-26 | 2003-03-25 | Guilford Pharmaceuticals, Inc. | Methods and compositions for treating solid tumors |
WO2001010416A1 (fr) * | 1999-08-11 | 2001-02-15 | Alkermes Controlled Therapeutics, Inc. | Procede d'administration d'un agent chimiotherapeutique a une tumeur solide |
WO2002003957A2 (fr) * | 2000-07-07 | 2002-01-17 | Guilford Pharmaceuticals, Inc. | Compositions a liberation prolongee de taxanes antineoplasiques et leurs procedes de preparation et d'utilisation |
AU2001280597A1 (en) * | 2000-07-17 | 2002-01-30 | Guilford Pharmaceuticals Inc. | Compositions for sustained release of analgesic agents, and methods of making and using the same |
AU2001296800A1 (en) | 2000-10-06 | 2002-04-15 | Johns Hopkins University | Systemic delivery of compounds through non-invasive bladder administration |
WO2002030472A2 (fr) * | 2000-10-12 | 2002-04-18 | Guilford Pharmaceuticals, Inc. | Compositions pour liberer des agents de radiosensibilisation, et procedes de production et d'utilisation de ces compositions |
US20020141966A1 (en) * | 2000-11-16 | 2002-10-03 | Wenbin Dang | Compositions for treatment of malignant effusions, and methods of making and using the same |
US20030133903A1 (en) * | 2001-07-19 | 2003-07-17 | Wenbin Dang | Compositions for treatment of prostate cancers and methods of making and using the same |
WO2003007915A2 (fr) * | 2001-07-19 | 2003-01-30 | Guilford Pharmaceuticals, Inc. | Compositions permettant le traitement de cancers de la tete et du cou, et procedes de fabrication et d'utilisation associes |
US20050238616A1 (en) * | 2002-01-09 | 2005-10-27 | Guilford Pharmaceuticals, Inc. | Compositions for treatment of central nervous system neoplasms, and methods of making and using the same |
ITMI20020680A1 (it) * | 2002-03-29 | 2003-09-29 | Acs Dobfar Spa | Composizione antitumorale migliorata a base di paclitaxel e metodo per il suo ottenimento |
US20050244402A1 (en) * | 2004-04-30 | 2005-11-03 | Villanueva Julie M | Absorption of pain-causing agents |
WO2006002365A2 (fr) * | 2004-06-24 | 2006-01-05 | Angiotech International Ag | Microparticules fortement chargees en agent bioactif |
US8563328B2 (en) * | 2004-07-26 | 2013-10-22 | University Of Louisville Research Foundation, Inc. | Fiber-optic biosensor and biosensing methods |
US7871573B2 (en) * | 2004-07-26 | 2011-01-18 | University Of Louisville Research Foundation, Inc. | Enhancement of sensitivity of fluorophore mediated biosensing and bioimaging |
US7517914B2 (en) * | 2005-04-04 | 2009-04-14 | Boston Scientificscimed, Inc. | Controlled degradation materials for therapeutic agent delivery |
US8580814B2 (en) * | 2006-04-03 | 2013-11-12 | Sunesis Pharmaceuticals, Inc. | Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4- oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer |
GB0525864D0 (en) * | 2005-12-20 | 2006-02-01 | Novartis Ag | Organic compounds |
EP3061791B1 (fr) | 2006-07-20 | 2019-01-16 | OrbusNeich Medical, Inc. | Composition polymère bioabsorbable pour un dispositif médical |
US20090169628A1 (en) * | 2006-10-17 | 2009-07-02 | Armark Authentication Technologies, Llc | Article and method for focused delivery of therapeutic and/or diagnostic materials |
US8691321B2 (en) | 2006-10-20 | 2014-04-08 | Orbusneich Medical, Inc. | Bioabsorbable polymeric composition and medical device background |
US7959942B2 (en) | 2006-10-20 | 2011-06-14 | Orbusneich Medical, Inc. | Bioabsorbable medical device with coating |
EP2222281B1 (fr) | 2007-12-20 | 2018-12-05 | Evonik Corporation | Procédé pour préparer des microparticules ayant un faible volume de solvant résiduel |
WO2009088777A1 (fr) * | 2007-12-31 | 2009-07-16 | Armark Authentication Technologies, Llc | Article et procédé d'administration focalisée de matières thérapeutiques et/ou de diagnostic |
WO2010037021A2 (fr) * | 2008-09-29 | 2010-04-01 | Armark Authentication Technologies, Llc | Filière et procédé de filage d’une fibre |
US20100291214A1 (en) * | 2008-12-23 | 2010-11-18 | Armark Authentication Technologies, Llc | Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure |
US20100291384A1 (en) * | 2009-05-15 | 2010-11-18 | Armark Authentication Technologies, Llc | Fiber having non-uniform composition and method for making same |
AU2012284147A1 (en) * | 2011-07-19 | 2014-02-27 | Stc. Unm | Intraperitoneally-administered nanocarriers that release their therapeutic load based on the inflammatory environment of cancers |
WO2013170069A1 (fr) | 2012-05-09 | 2013-11-14 | Massachusetts Institute Of Technology | Médicament, méthode, et dispositif d'administration de médicament pour le traitement du cancer de l'ovaire |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA597473A (en) | 1960-05-03 | Starck Werner | Process for the manufacture of phosphorus-containing polyesters and copolymers thereof | |
US2891915A (en) | 1954-07-02 | 1959-06-23 | Du Pont | Organophosphorus polymers |
US3271329A (en) | 1958-09-19 | 1966-09-06 | Eastman Kodak Co | Method for producing polymers derived from phosphites and glycols |
US3442982A (en) | 1965-10-15 | 1969-05-06 | Weston Chemical Corp | Polyphosphites of 2,2-dimethyl-3-hydroxypropyl - 2 - dimethyl - 3-hydroxypropionate |
FR2219193B1 (fr) | 1973-02-28 | 1976-05-21 | Rhone Poulenc Sa | |
US3932566A (en) | 1974-09-16 | 1976-01-13 | Celanese Corporation | Phosphonate polymers |
US4100354A (en) | 1976-08-05 | 1978-07-11 | Owens-Corning Fiberglass Corporation | Terephthalate ester polyols |
US4259222A (en) | 1978-08-16 | 1981-03-31 | Basf Wyandotte Corporation | Linear saturated polyesters of phosphoric acid and halogenated diols as flame-retardant additives and coatings |
DE2925206A1 (de) | 1979-06-22 | 1981-01-29 | Bayer Ag | Aromatische polyesterphosphonate, verfahren zu ihrer herstellung und ihre verwendung zur herstellung thermoplastischer formkoerper |
FR2498612A1 (fr) | 1981-01-26 | 1982-07-30 | Peters Ligatures | Nouveaux polymeres insolubles a biodegradabilite reglable a volonte, leurs procedes de preparation et leur application en tant que biomateriaux |
US4757128A (en) | 1986-08-01 | 1988-07-12 | Massachusetts Institute Of Technology | High molecular weight polyanhydride and preparation thereof |
US4474937A (en) | 1983-10-03 | 1984-10-02 | The Dow Chemical Company | Phosphorus-modified polyestercarbonate resins |
US4481353A (en) | 1983-10-07 | 1984-11-06 | The Children's Medical Center Corporation | Bioresorbable polyesters and polyester composites |
US4746462A (en) | 1985-02-21 | 1988-05-24 | Dainichiseika Color & Chemicals Mfg. Co., Ltd. | Phosphoric ester compound |
US4789724A (en) | 1986-10-17 | 1988-12-06 | Massachusetts Institute Of Technology | Preparation of anhydride copolymers |
US4978332A (en) | 1987-09-28 | 1990-12-18 | Matrix Pharmaceutical, Inc. | Treatments employing vasoconstrictive substances in combination with cytotoxic agents for introduction into cellular lesion areas |
US5256765A (en) | 1989-03-09 | 1993-10-26 | The Johns Hopkins University School Of Medicine | Biodegradable poly(phosphate esters) |
US5194581A (en) | 1989-03-09 | 1993-03-16 | Leong Kam W | Biodegradable poly(phosphoesters) |
US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
NO302481B1 (no) | 1990-10-16 | 1998-03-09 | Takeda Chemical Industries Ltd | Polymer for et preparat med forlenget frigjöring, samt preparat med forlenget frigjöring |
US5429634A (en) | 1993-09-09 | 1995-07-04 | Pdt Systems | Biogenic implant for drug delivery and method |
US5886026A (en) | 1993-07-19 | 1999-03-23 | Angiotech Pharmaceuticals Inc. | Anti-angiogenic compositions and methods of use |
CA2180260A1 (fr) | 1993-12-29 | 1995-07-06 | Dennis M. Brown | Procedes et compositions utilises dans le traitement d'un hote affecte par une maladie a proliferation cellulaire |
DE4404365A1 (de) | 1994-02-11 | 1995-08-17 | Cassella Ag | Phosphin- und phosphonsäuregruppenhaltige Polykondensate |
US5626862A (en) | 1994-08-02 | 1997-05-06 | Massachusetts Institute Of Technology | Controlled local delivery of chemotherapeutic agents for treating solid tumors |
WO1996022786A1 (fr) | 1995-01-23 | 1996-08-01 | Takeda Chemical Industries, Ltd. | Preparation a diffusion prolongee et son emploi |
US5637085A (en) | 1995-11-20 | 1997-06-10 | Cardinale; Robert M. | Method of cancer tumor treatment by slow release delivery of 1,2,4-benzotriazine oxides to tumor site |
EP0895517B1 (fr) | 1996-04-23 | 2004-11-17 | Ipsen Manufacturing Ireland Limited | Polymeres polylactiques acides |
US5993856A (en) | 1997-01-24 | 1999-11-30 | Femmepharma | Pharmaceutical preparations and methods for their administration |
CA2285391A1 (fr) | 1997-03-27 | 1998-10-01 | Baker Norton Pharmaceuticals, Inc. | Procedes et compositions pour le traitement du cancer des ovaires |
UA54505C2 (uk) | 1997-04-03 | 2003-03-17 | Гілфорд Фармасьютікалз Інк. | Полімери, що біологічно розкладаються, зшиті фосфатами, композиції, вироби і способи для їх виготовлення і використання |
ATE279461T1 (de) | 1997-04-03 | 2004-10-15 | Guilford Pharm Inc | Bioabbaubare terephthalat polyester-polyphosphat polymere, zusammensetzungen, gegenstände und verfahren für ihre herstellung und verwendung |
US5912225A (en) | 1997-04-14 | 1999-06-15 | Johns Hopkins Univ. School Of Medicine | Biodegradable poly (phosphoester-co-desaminotyrosyl L-tyrosine ester) compounds, compositions, articles and methods for making and using the same |
KR20010020432A (ko) | 1997-04-30 | 2001-03-15 | 토마스 씨. 서 | 폴리(고리지방족 포스포에스테르) 화합물로 이루어진 생분해성 조성물, 약품 및 그의 이용방법 |
JP2002515939A (ja) | 1997-06-18 | 2002-05-28 | ギルフォード ファーマシュウティカルズ インコーポレイテッド | 高分子量ポリホスホエステルの2段溶液重合法 |
US6028163A (en) | 1997-06-27 | 2000-02-22 | Guilford Pharmaceuticals Inc. | Solution polymerization of high molecular weight poly(phosphoesters) in toluene |
US6153212A (en) * | 1998-10-02 | 2000-11-28 | Guilford Pharmaceuticals Inc. | Biodegradable terephthalate polyester-poly (phosphonate) compositions, articles, and methods of using the same |
US6419709B1 (en) | 1998-10-02 | 2002-07-16 | Guilford Pharmaceuticals, Inc. | Biodegradable terephthalate polyester-poly(Phosphite) compositions, articles, and methods of using the same |
CA2345240A1 (fr) | 1998-10-02 | 2000-04-13 | David P. Nowotnik | Compositions et articles a base de polyester-poly(phosphonate) et polyester-poly(phosphite) de terephthalate biodegradables, techniques d'utilisation |
US6537585B1 (en) * | 1999-03-26 | 2003-03-25 | Guilford Pharmaceuticals, Inc. | Methods and compositions for treating solid tumors |
EP1171117A4 (fr) | 1999-04-22 | 2002-08-07 | American Bioscience Inc | Administration a long terme d'agents pharmacologiquement actifs |
-
1999
- 1999-01-11 US US09/227,852 patent/US6350464B1/en not_active Expired - Fee Related
- 1999-02-25 IL IL14508799A patent/IL145087A0/xx unknown
- 1999-12-23 EP EP99964321A patent/EP1140028B1/fr not_active Expired - Lifetime
- 1999-12-23 BR BR9916881-2A patent/BR9916881A/pt not_active Application Discontinuation
- 1999-12-23 CN CN99816287A patent/CN1337878A/zh active Pending
- 1999-12-23 RU RU2001122708/15A patent/RU2001122708A/ru unknown
- 1999-12-23 WO PCT/US1999/030814 patent/WO2000041678A1/fr active IP Right Grant
- 1999-12-23 DE DE69928567T patent/DE69928567T2/de not_active Expired - Lifetime
- 1999-12-23 KR KR1020017008774A patent/KR20010101472A/ko not_active Application Discontinuation
- 1999-12-23 AU AU20591/00A patent/AU779182B2/en not_active Expired - Fee Related
- 1999-12-23 JP JP2000593290A patent/JP2002534456A/ja active Pending
- 1999-12-23 CZ CZ20012416A patent/CZ20012416A3/cs unknown
- 1999-12-23 AT AT99964321T patent/ATE310506T1/de not_active IP Right Cessation
- 1999-12-23 MX MXPA01007018 patent/MX236541B/es not_active IP Right Cessation
- 1999-12-23 CA CA2359109A patent/CA2359109C/fr not_active Expired - Fee Related
- 1999-12-23 HU HU0202670A patent/HUP0202670A3/hu unknown
- 1999-12-23 IL IL14408799A patent/IL144087A0/xx unknown
- 1999-12-23 TR TR2001/02012T patent/TR200102012T2/xx unknown
-
2001
- 2001-03-28 US US09/819,376 patent/US6479067B2/en not_active Expired - Fee Related
- 2001-07-09 NO NO20013402A patent/NO20013402L/no not_active Application Discontinuation
- 2001-07-25 IN IN1053CH2001 patent/IN2001CH01053A/xx unknown
- 2001-08-07 ZA ZA200106499A patent/ZA200106499B/xx unknown
-
2002
- 2002-10-04 US US10/264,793 patent/US6641833B2/en not_active Expired - Fee Related
-
2003
- 2003-08-14 US US10/641,301 patent/US20040071774A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CZ20012416A3 (cs) | 2001-11-14 |
CN1337878A (zh) | 2002-02-27 |
CA2359109A1 (fr) | 2000-07-20 |
EP1140028B1 (fr) | 2005-11-23 |
CA2359109C (fr) | 2011-02-22 |
US6641833B2 (en) | 2003-11-04 |
BR9916881A (pt) | 2002-05-07 |
AU779182B2 (en) | 2005-01-13 |
US6479067B2 (en) | 2002-11-12 |
MXPA01007018A (es) | 2005-07-01 |
HUP0202670A2 (hu) | 2002-11-28 |
HUP0202670A3 (en) | 2003-02-28 |
AU2059100A (en) | 2000-08-01 |
JP2002534456A (ja) | 2002-10-15 |
US6350464B1 (en) | 2002-02-26 |
NO20013402L (no) | 2001-09-11 |
MX236541B (es) | 2006-05-04 |
EP1140028A1 (fr) | 2001-10-10 |
IL144087A0 (en) | 2002-05-23 |
IL145087A0 (en) | 2002-06-30 |
US20010038849A1 (en) | 2001-11-08 |
WO2000041678A1 (fr) | 2000-07-20 |
RU2001122708A (ru) | 2004-02-20 |
ATE310506T1 (de) | 2005-12-15 |
KR20010101472A (ko) | 2001-11-14 |
DE69928567T2 (de) | 2006-08-17 |
TR200102012T2 (tr) | 2002-01-21 |
DE69928567D1 (de) | 2005-12-29 |
US20030138493A1 (en) | 2003-07-24 |
IN2001CH01053A (en) | 2005-03-04 |
US20040071774A1 (en) | 2004-04-15 |
NO20013402D0 (no) | 2001-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200106499B (en) | Methods for treating ovarian cancer, poly(phosphoester) compositions, and biodegradable articles for same. | |
IL145492A0 (en) | Methods and compositions for treating solid tumors | |
WO2001024763A3 (fr) | Compositions et methodes de traitement du cancer utilisant des immunoconjugues et des agents chimiotherapeutiques | |
AP1553A (en) | Tricyclic inhibitors of poly (ADP-Ribose) polymerases. | |
CA2292359A1 (fr) | Nouveaux azalides et procede de fabrication | |
MY140398A (en) | 4-AMINO-6-PHENYL-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES | |
MXPA02003203A (es) | Composiciones terapeuticas solubles en tocol. | |
HK1053115A1 (en) | Quinazoline derivatives for the treatment of tumours. | |
GEP20033079B (en) | Pharmaceutical Compositions for Treatment of Diseases Caused by Estrogens Deficiency | |
GEP20043250B (en) | Use of Indolyl-3-Glyoxylic Acid Derivatives as Anti-tumor Means and Pharmaceutical Compositions Containing the Same | |
SG165162A1 (en) | Modified release pharmaceutical formulation | |
PL342614A1 (en) | Anticarcinogenic drugs | |
CZ16395A3 (en) | Inclusion complexes of nimesulid salts of alkali metals and alkaline earth metals with cyclodextrins, process of their preparation and pharmaceutical compositions containing thereof | |
ATE363909T1 (de) | Pharmazeutische zusammensetzungen mit wundheilender und anti-komplementärer wirkung die ein dextranderivat enthalten | |
IL163608A (en) | Sulfonanilides are conserved in their amino / amino acids and derivatives, their process, their pharmaceutical preparations, and their conjugated antibodies and their use in the preparation of drugs for the treatment of culture disorders | |
AU6749401A (en) | Use of aloe-emodin in the treatment of neuroectodermal tumors | |
YU46302A (sh) | Supstituisani piroli | |
YU19302A (sh) | 4-benzilaminohinolin konjugovan žučnom kiselinom i njegovi heteroanalozi, postupak za njihovu proizvodnju, lekovi koji sadrže ta jedinjenja i njihova primena | |
AP9901559A0 (en) | Tricyclic 3-keto derivatives of 6-0-methylerythromycin. | |
AP2002002494A0 (en) | Hygromycin derivatives. | |
CA2392902A1 (fr) | Bisindolylmaleimides substitues destines a inhiber la proliferation cellulaire | |
WO2002008231A3 (fr) | Macrolides biologiquement actifs, compositions, et leurs utilisations |